Skip to main content
Monday, November 16, 2026Nov 16

Missouri attorney general sues drug companies over opioids

Missouri Attorney General Josh Hawley speaks at a news conference Wednesday, June 21, 2017, in St. Louis where announced he is suing three large pharmaceutical companies, saying their deceptive marketing practices contributed to an opioid abuse crisis in the state. Looking on at left is Jammie Fabick, whose 17-year-old daughter died of an opioid overdose in 2014. (AP Photo/Jim Salter)
Missouri Attorney General Josh Hawley speaks at a news conference Wednesday, June 21, 2017, in St. Louis where announced he is suing three large pharmaceutical companies, saying their deceptive marketing practices contributed to an opioid abuse crisis in the state. Looking on at left is Jammie Fabick, whose 17-year-old daughter died of an opioid overdose in 2014. (AP Photo/Jim Salter)

ST. LOUIS (AP) – Missouri Attorney General Josh Hawley on Wednesday filed suit against three large pharmaceutical companies, saying their “campaign of fraud and deception” led to a startling opioid crisis in the state.

Hawley, a Republican, filed suit St. Louis Circuit Court, naming Endo Pharmaceuticals, Purdue Pharma, and Janssen Pharmaceuticals. Hawley said at a news conference that the suit will seek “hundreds of millions of dollars” in both damages and civil penalties.

Hawley said the three companies over several years misrepresented the addictive risks of opioids, often using fraudulent science to back their claims. As a result, thousands of Missourians dealing with chronic pain were given unnecessary opioid prescriptions.

“For years now, the citizens of Missouri have been the victims of a coordinated campaign of fraud and deception about the nature of drugs known as opioids,” Hawley said. The companies named in the suit “have profited from the suffering of Missourians,” he said.

Officials with Janssen and Purdue Pharma said in statements that their companies share concerns about the opioid crisis, but both denied wrongdoing. Janssen spokeswoman Jessica Castles Smith said the company “has acted appropriately, responsibly and in the best interests of patients regarding our opioid pain medications …” Purdue Pharma said the company “vigorously” denied the allegations in the lawsuit and is an industry leader in developing “abuse-deterrent technology.”